Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.034
Schlusskurs vom Vortag:
$0.034
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$3.74M
Einnahmen:
$12.00M
Nettoeinkommen (Verlust:
$-63.23M
KGV:
0.00
EPS:
-6
Netto-Cashflow:
$-43.02M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$2.09
Accelerate Diagnostics Inc Stock (AXDX) Company Profile
Firmenname
Accelerate Diagnostics Inc
Sektor
Branche
Telefon
303-863-8088
Adresse
3950 S. COUNTRY CLUB ROAD #470, TUCSON, AZ
Vergleichen Sie AXDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXDX
Accelerate Diagnostics Inc
|
0.00 | 3.74M | 12.00M | -63.23M | -43.02M | -6.00 |
|
ABT
Abbott Laboratories
|
134.93 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.96 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
393.11 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.56 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.65 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-03-09 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-10-08 | Eingeleitet | BTIG Research | Neutral |
| 2020-08-07 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-09-27 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-05-24 | Eingeleitet | Craig Hallum | Hold |
| 2017-12-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2017-07-12 | Fortgesetzt | BTIG Research | Buy |
| 2016-03-24 | Eingeleitet | JP Morgan | Overweight |
| 2015-12-16 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Accelerate Diagnostics Inc Aktie (AXDX) Neueste Nachrichten
Company earnings calendar - Yahoo
Court approves stalking horse bidder in Accelerate Diagnostics bankruptcy sale - The Business Journals
Med Tech Co. Accelerate Diagnostics Can Tap $20M DIP Loan - Law360
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform - The Manila Times
ProPhase Labs Announces Formation of Clinical Science - GlobeNewswire
Bidding Procedure Approved for Accelerate Diagnostics, Inc. - marketscreener.com
Accelerate Diagnostics Files for Chapter 11 Bankruptcy - TipRanks
QuidelOrtho Makes Major Molecular Diagnostics Pivot: $100M LEX Acquisition to Replace Savanna Platform - Stock Titan
Accelerate Diagnostics CFO Resignation Announced - TipRanks
Healthcare Spending Slowdown Sparked Accelerate's Ch. 11 - Law360
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated at StockNews.com - Defense World
Life-saving healthcare company files for Chapter 11 bankruptcy - MSN
Major health care company files for bankruptcy to sell assets - TheStreet
Accelerate Diagnostics Delays 10-Q Filing Amid Bankruptcy - TipRanks
Accelerate Diagnostics (AXDX) Options Delisted Effective May 15t - GuruFocus
Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings - Benzinga
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.21% - Investing.com
Catching Up With New Bankruptcy Case Action - Law360
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
Accelerate Diagnostics, Inc.(NasdaqCM: AXDX) dropped from S&P TMI Index - marketscreener.com
Accelerate Diagnostics files for Chapter 11 bankruptcy, seeks asset sale amid financial strain - ABC15 Arizona
Accelerate Diagnostics (AXDX) to Release Earnings on Wednesday - Defense World
Arizona-Based Accelerate Diagnostics Files for Bankruptcy, Plans Asset Sale - NewsBreak: Local News & Alerts
Post-Trade Analysis: Accelerate Diagnostics Inc (AXDX) Slides -70.39, Closing at 0.14 - DWinneX
Accelerate Diagnostics initiates Chapter 11 and asset sale By Investing.com - Investing.com Nigeria
Accelerate Diagnostics files for Chapter 11 - USA Herald
Biotech Co. Accelerate Diagnostics Hits Ch. 11 With Sale Plan - Law360
Accelerate Diagnostics Files For Chapter 11 Protection And Agrees To Terms To Sell Substantially All Assets - marketscreener.com
Accelerate Diagnostics (AXDX) Starts Chapter 11 for Asset Sale | - GuruFocus
Accelerate Diagnostics Initiates Chapter 11 Restructuring Proceeding - Nasdaq
Accelerate Diagnostics initiates Chapter 11 and asset sale - Investing.com
Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets - Stock Titan
Accelerate Diagnostics files for Chapter 11 bankruptcy - marketscreener.com
Motion for Joint Administration Filed by Accelerate Diagnostics, Inc. - marketscreener.com
Accelerate Diagnostics, Inc. Filed for Bankruptcy - marketscreener.com
Renaissance Technologies LLC Grows Position in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Defense World
Accelerate Diagnostics (NASDAQ:AXDX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Short Interest Update - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Raymond James Has Negative Forecast for TSE:BEI Q1 Earnings - The AM Reporter
Accelerate Diagnostics, Inc. to Host Earnings Call - ACCESS Newswire
Accelerate Diagnostics grants CEO retention bonus - Investing.com Australia
Accelerate Diagnostics grants CEO retention bonus By Investing.com - Investing.com Canada
Accelerate Diagnostics CEO Retention Bonus Agreement - TipRanks
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Sees Significant Decrease in Short Interest - Defense World
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs - The Manila Times
Finanzdaten der Accelerate Diagnostics Inc-Aktie (AXDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.19%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):